Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-16

Clinical Trial Update: Hydroxychloroquine in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating hydroxychloroquine in patients with rising PSA after local therapy for prostate cancer has completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-06-16